Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

“Trailblazing” Lyme Disease Researchers to Be Honored at Lyme Research Alliance Gala
  • USA - English


News provided by

Lyme Research Alliance

Mar 12, 2014, 13:00 ET

Share this article

Share toX

Share this article

Share toX


Greenwich, CT (PRWEB) March 12, 2014 -- Two distinguished Lyme disease researchers—Kim Lewis, Ph.D. of Northeastern University and Ying Zhang, M.D., Ph.D., of Johns Hopkins Bloomberg School of Public Health—will each receive the Lauren F. Brooks Hope Award at Lyme Research Alliance’s “Time for Lyme” Gala, April 5, 2014, at the Hyatt Regency Greenwich in Old Greenwich, CT. The Award honors those who are making strides in research and treatment in the pursuit of a Lyme disease cure.

Recurrent infections are not just a problem in late stage Lyme disease, but a major dilemma for surgeons and patients dealing with artificial heart valves, prosthetic joints, and diseases such as tuberculosis and cystic fibrosis.

Post this

Both scientists are deeply involved in researching “persisters,” cells that manage to survive antibiotic assault. Unlike some cells that are literally resistant and can live and replicate normally in the presence of a drug, mysterious persister cells neither die nor grow in the presence of an antibiotic. Rather, they exist in a dormant state that allows them to survive antibiotic treatment, only to awaken later and start a new wave of infection.

“We are thankful that these two brilliant scientists are trailblazing research into persister organisms," said Harriet Kotsoris, M.D., LRA’s chief scientific officer. “Recurrent infections are not just a problem in late stage Lyme disease, but a major dilemma for surgeons and patients dealing with artificial heart valves, prosthetic joints, and diseases such as tuberculosis and cystic fibrosis,” she said. “Researchers are working fast and furiously to find better treatments to reduce not only morbidity, but mortality, associated with antibiotic tolerance. Drs. Zhang and Lewis, both LRA grantees, are at the forefront of this work.”

In November, Dr. Lewis, distinguished professor and director of Northeastern’s Antimicrobial Discovery Center, announced his research had led to a treatment to cure the “superbug” MRSA in a variety of laboratory experiments and in a mouse model of chronic MRSA infection. Dr. Lewis and his team found that a drug called ADEP wakes up dormant persisters and then initiates a self-destruct mechanism.
 
By coupling ADEP with a traditional antibiotic, Dr. Lewis and his team were able to completely destroy the MRSA cells. Dr. Lewis’ team believes similar compounds will be useful for treating other infections as well, and they are testing ADEP against the Lyme disease spirochete, Borrelia burgdorferi (Bb).

LRA’s other honoree, Dr. Zhang, professor of molecular microbiology and immunology at the Bloomberg School of Public Health at Johns Hopkins University, has demonstrated that the drug Pyrazinamide (PZA) is uniquely effective against tuberculosis bacteria that have transitioned into a persister state, tolerant to most antibiotics. He is testing compounds singly, and in combination with the PZA, to find an optimal treatment regimen for patients with chronic Lyme disease.

LRA’s “Time for Lyme” Gala, its largest fundraiser of the year, helps to fund important medical research projects. LRA is the leading private nonprofit organization funding cutting-edge research into the prevention, diagnosis and treatment of Lyme and other tick-borne diseases by universities and major U.S. medical institutions.

The Gala is shaping up to be an exciting event with television personality Gretchen Carlson, herself a Lyme disease sufferer, serving as Mistress of Ceremonies. Elena Delle Donne—the reigning Women’s National Basketball Association’s (WNBA) Rookie of the Year—will receive the organization’s “StarLight” Award for raising awareness about Lyme disease. In addition, a veritable Who’s Who list of celebrities, including actor Peter Sarsgaard; designer Tommy Hilfiger; baseball Hall of Famer Tom Seaver; actress Jane Alexander; Real Housewives of Beverly Hills co-star Yolanda Foster and others, have signed on as Honorary Event Chairs.

The Gala will be held Saturday, April 5 from 6:30 p.m. to midnight at the Hyatt Regency Greenwich in Old Greenwich, CT. The evening features dinner, dancing and a live auction.

Ticket Information

Tickets may be purchased online by visiting http://www.LymeResearchAlliance.org and clicking on the homepage box, or by calling 203-969-1333.
___________________________________________________________________________________

Lyme Research Alliance, formerly Time for Lyme, is a Connecticut-based, national non-profit that funds cutting-edge research into Lyme and other tick-borne diseases. For more information, go to http://www.LymeResearchAlliance.org.

Peter Wild, Lyme Research Alliance, http://www.lymeresearchalliance.org, +1 203-448-8801, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.